BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4853253)

  • 1. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.
    Nishikai M; Funatsu Y; Homma M
    Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive systemic sclerosis and polymyositis.
    Silas AM; White AG
    Proc R Soc Med; 1976 Nov; 69(11):808-9. PubMed ID: 1005459
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymyositis due to D-penicillamine in a patient with systemic sclerosis.
    Santos JC; Velasco JA
    Clin Exp Dermatol; 1991 Jan; 16(1):76. PubMed ID: 2025947
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary biliary cirrhosis in systrmic sclerosis (scleroderma) and polymyositis.
    Uhl GS; Baldwin JL; Arnett FC
    Johns Hopkins Med J; 1974 Sep; 135(3):191-8. PubMed ID: 4415197
    [No Abstract]   [Full Text] [Related]  

  • 5. Penicillamine-induced myositis in rheumatoid arthritis.
    Morgan GJ; McGuire JL; Ochoa J
    Muscle Nerve; 1981; 4(2):137-40. PubMed ID: 7207503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymyositis induced by D-penicillamine].
    Brousson A; Pélissier J; Lepeu G; Pages M; Huttel JM; Blotman F; Bertrand A; Simon L
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):267-71. PubMed ID: 7221458
    [No Abstract]   [Full Text] [Related]  

  • 7. Penicillamine-induced polymyositis.
    Leden I; Libelius R
    Scand J Rheumatol; 1985; 14(1):90-3. PubMed ID: 4001884
    [No Abstract]   [Full Text] [Related]  

  • 8. D-penicillamine-induced myositis in rheumatoid arthritis.
    Chappel R; Willems J
    Clin Rheumatol; 1996 Jan; 15(1):86-7. PubMed ID: 8929785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive systemic sclerosis with pancytopenia, polymyositis and complete heart block developing after D-penicillamine therapy: a case report].
    Matsumura T; Kabashima T; Kono I; Yamane K; Sakurai T; Yamaguchi I; Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1985 Jul; 74(7):958-63. PubMed ID: 4056558
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammatory ocular myopathy in systemic sclerosis (scleroderma). A case report and review of the literature.
    Arnett FC; Michels RG
    Arch Intern Med; 1973 Nov; 132(5):740-3. PubMed ID: 4750227
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic effect of d-penicillamine in scleroderma].
    Bogdanikowa B; Rudy J; Bernacka K; Palka Z
    Pol Tyg Lek; 1973 Aug; 28(34):1317-20. PubMed ID: 4756401
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic lupus erythematosus, polymyositis, and progressive systemic sclerosis (scleroderma).
    Zilko PJ; Dawkins RL
    Med J Aust; 1979 Apr; 1(S2):24-7. PubMed ID: 449747
    [No Abstract]   [Full Text] [Related]  

  • 13. Discordant response to rituximab in a systemic sclerosis patient with associated myositis.
    Fabri M; Hunzelmann N; Krieg T; Rubbert A
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S127-8. PubMed ID: 18489049
    [No Abstract]   [Full Text] [Related]  

  • 14. Vesicular lesions in a woman with progressive systemic sclerosis. Penicillamine-induced intradermal vesicles: an example of human lathyrism.
    Godar JM; Norins AL
    Arch Dermatol; 1992 Jul; 128(7):977-8, 980-1. PubMed ID: 1626968
    [No Abstract]   [Full Text] [Related]  

  • 15. Two years of penicillamine for progressive systemic sclerosis: a case report.
    Thomson J; Milne JA
    Postgrad Med J; 1974 Aug; 50 Suppl 2():36-8. PubMed ID: 4467175
    [No Abstract]   [Full Text] [Related]  

  • 16. [Scleroderma and IgA monoclonal gammopathy].
    Valdés Oliveras M; Bosch Gil JA; Oristrell Salvá J; San José Laporte A; Knobel Freud H
    Rev Clin Esp; 1985 Dec; 177(9):472. PubMed ID: 4095320
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience using d-penicillamine in systemic scleroderma].
    Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP
    Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046
    [No Abstract]   [Full Text] [Related]  

  • 18. D-penicillamine-induced polymyositis.
    Wouters JM; Van de Putte LB; Renier WO; Joosten EM
    Neth J Med; 1982; 25(6):159-62. PubMed ID: 7121648
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited cutaneous systemic sclerosis with myositis showing drug-induced liver injury and thrombotic microangiopathy.
    Kokubu H; Tsukamoto Y; Takahashi T; Muro Y; Fujimoto N
    Int J Rheum Dis; 2023 Jul; 26(7):1395-1398. PubMed ID: 36808881
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasmapheresis in polymyositis and progressive systemic sclerosis].
    Shimada K; Koh CS; Yanagisawa N
    Nihon Rinsho; 1992 Jan; 50 Suppl():325-9. PubMed ID: 1578703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.